CVS · CVS Health Corporation Common Stock
View on chartInsiders & Stakes
| Larry Robbins | ▼ Sell | Open Market | 4,824,799 Shares held | 5/21/2026 | View profile |
| Roberts Jonathan C EVP & Chief Operating Officer | ▲ Buy | Grant | 426,025 Shares held | 2/21/2022 | View profile |
| Moriarty Thomas M EVP General Counsel & CPO | ▼ Sell | Tax Withholding | 315,273 Shares held | 12/31/2022 | View profile |
| Brennan Troyen A EVP and Chief Medical Officer | ▼ Sell | Tax Withholding | 232,676 Shares held | 4/3/2022 | View profile |
| C. David Brown II Director | ▲ Buy | Grant | 129,316 Shares held | 5/14/2026 | View profile |
| PELUSO MICHELLE A Director | ▼ Sell | Tax Withholding | 124,383 Shares held | 4/1/2023 | View profile |
| David W. Dorman Director | ▲ Buy | Grant | 109,875 Shares held | 5/11/2022 | View profile |
| Lotvin Alan EVP&President-PharmacyServices | ▼ Sell | Open Market | 109,183 Shares held | 8/4/2022 | View profile |
| Karen S. Lynch Director | ▼ Sell | Tax Withholding | 74,687 Shares held | 4/1/2024 | View profile |
| J. David Joyner EVP&President-PharmacyServices | ▼ Sell | Tax Withholding | 70,349 Shares held | 4/1/2026 | View profile |
| Prem S. Shah EVP and Co-President of Retail | ▼ Sell | Tax Withholding | 64,356 Shares held | 4/1/2026 | View profile |
| COWHEY THOMAS F. SVP, Interim CFO | ▲ Buy | Grant | 41,109 Shares held | 4/1/2025 | View profile |
| WHITE TONY L Director | ▲ Buy | Grant | 37,852 Shares held | 5/11/2022 | View profile |
| Havanec Laurie P. Director | ▼ Sell | Tax Withholding | 37,553 Shares held | 4/1/2024 | View profile |
| Finke Daniel P EVP/Pres, Health Care Benefits | ▼ Sell | Tax Withholding | 35,068 Shares held | 4/1/2023 | View profile |
| DEPARLE NANCY ANN Director | ▲ Buy | Grant | 34,169 Shares held | 11/21/2024 | View profile |
| Samrat S. Khichi EVP, CPO and General Counsel | ▼ Sell | Tax Withholding | 33,421 Shares held | 4/1/2026 | View profile |
| James David Clark SVP, Cont & Chief Acct Officer | ▼ Sell | Tax Withholding | 27,606 Shares held | 6/26/2026 | View profile |
| Chaguturu Sreekanth K EVP and Chief Medical Officer | ▲ Buy | Grant | 23,666 Shares held | 4/1/2024 | View profile |
| Edward J. Ludwig Director | ▲ Buy | Open Market | 21,630 Shares held | 5/2/2024 | View profile |
| Roger N. Farah Director | ▼ Sell | Tax Withholding | 19,438 Shares held | 11/30/2025 | View profile |
| Jeffrey R. Balser Director | ▲ Buy | Grant | 15,717 Shares held | 5/14/2026 | View profile |
| Guy P. Sansone Director | ▲ Buy | Grant | 15,106 Shares held | 5/14/2026 | View profile |
| J. Scott Kirby Chief Executive Officer | ▲ Buy | Grant | 14,434 Shares held | 5/14/2026 | View profile |
| Heidi B. Capozzi EVP and Chief People Officer | ▼ Sell | Tax Withholding | 13,023 Shares held | 4/1/2026 | View profile |
| Kane Brian A EVP/President, Aetna | ▲ Buy | Grant | 12,569 Shares held | 4/1/2024 | View profile |
| Fernando Aguirre Director | ▼ Sell | Other | 10,513 Shares held | 5/21/2026 | View profile |
| Tilak Mandadi EVP, Chief Technology Officer | ▼ Sell | Open Market | 10,133 Shares held | 5/8/2026 | View profile |
| Amy Compton-Phillips EVP, Chief Medical Officer | ▼ Sell | Tax Withholding | 9,557 Shares held | 5/31/2026 | View profile |
| Mary L. Schapiro Director | ▲ Buy | Grant | 7,585 Shares held | 11/17/2021 | View profile |
| Leslie Norwalk V Director | ▲ Buy | Grant | 7,376 Shares held | 5/14/2026 | View profile |
| Michael F. Mahoney Director | ▲ Buy | Grant | 6,345 Shares held | 5/15/2025 | View profile |
| Douglas H. Shulman Director | ▲ Buy | Grant | 5,929 Shares held | 11/20/2025 | View profile |
| MILLON JEAN PIERRE Director | ▲ Buy | Grant | 4,514 Shares held | 11/21/2024 | View profile |
| Brian Newman Director | ▼ Sell | Tax Withholding | 3,008 Shares held | 5/31/2026 | View profile |
| Steven H. Nelson EVP and President, Aetna | ▼ Sell | Tax Withholding | 2,900 Shares held | 4/1/2026 | View profile |
| Finucane Anne A. Director | ▲ Buy | Grant | 591 Shares held | 11/20/2025 | View profile |
| John E. Gallina Director | ▲ Buy | Grant | 582 Shares held | 3/19/2026 | View profile |
Transaction History
| James David Clark | ▼ Sell | Tax Withholding | 454 | $41K | 6/26/2026 |
| Brian Newman | ▼ Sell | Tax Withholding | 2,478 | $225K | 5/31/2026 |
| Amy Compton-Phillips | ▼ Sell | Tax Withholding | 7,618 | $693K | 5/31/2026 |
| Larry Robbins | ▼ Sell | Open Market | 370,462 | $34.6M | 5/21/2026 |
| Fernando Aguirre | ▼ Sell | Other | 1,563 | $146K | 5/21/2026 |
| Larry Robbins | ▼ Sell | Open Market | 797,628 | $74.6M | 5/20/2026 |
| Larry Robbins | ▼ Sell | Open Market | 152,691 | $14.5M | 5/20/2026 |
| Larry Robbins | ▼ Sell | Open Market | 66,881 | $6.4M | 5/20/2026 |
| Larry Robbins | ▼ Sell | Open Market | 800 | $77K | 5/20/2026 |
| Fernando Aguirre | ▼ Sell | Other | 30,437 | $2.9M | 5/20/2026 |
| Larry Robbins | ▼ Sell | Open Market | 151 | $14K | 5/19/2026 |
| Larry Robbins | ▼ Sell | Open Market | 1,983,387 | $187.3M | 5/19/2026 |
| Fernando Aguirre | ▲ Buy | Grant | 1,563 | $152K | 5/14/2026 |
| Jeffrey R. Balser | ▲ Buy | Grant | 2,058 | $200K | 5/14/2026 |
| J. Scott Kirby | ▲ Buy | Grant | 1,447 | $141K | 5/14/2026 |
| Leslie Norwalk V | ▲ Buy | Grant | 1,447 | $141K | 5/14/2026 |
| Guy P. Sansone | ▲ Buy | Grant | 1,447 | $141K | 5/14/2026 |
| C. David Brown II | ▲ Buy | Grant | 1,544 | $150K | 5/14/2026 |
| Tilak Mandadi | ▼ Sell | Open Market | 69,551 | $6.2M | 5/8/2026 |
| Prem S. Shah | ▼ Sell | Tax Withholding | 1,484 | $108K | 4/1/2026 |
| Steven H. Nelson | ▼ Sell | Tax Withholding | 2,432 | $176K | 4/1/2026 |
| Tilak Mandadi | ▼ Sell | Tax Withholding | 3,634 | $263K | 4/1/2026 |
| Samrat S. Khichi | ▼ Sell | Tax Withholding | 3,541 | $257K | 4/1/2026 |
| J. David Joyner | ▼ Sell | Tax Withholding | 8,029 | $582K | 4/1/2026 |
| James David Clark | ▼ Sell | Tax Withholding | 3,262 | $236K | 4/1/2026 |
| Heidi B. Capozzi | ▼ Sell | Tax Withholding | 1,334 | $97K | 4/1/2026 |
| Prem S. Shah | ▲ Buy | Grant | 25,062 | $1.8M | 3/31/2026 |
| Brian Newman | ▲ Buy | Grant | 19,493 | $1.4M | 3/31/2026 |
| Steven H. Nelson | ▲ Buy | Grant | 22,277 | $1.6M | 3/31/2026 |
| Tilak Mandadi | ▲ Buy | Grant | 22,277 | $1.6M | 3/31/2026 |
| Samrat S. Khichi | ▲ Buy | Grant | 12,531 | $900K | 3/31/2026 |
| J. David Joyner | ▲ Buy | Grant | 86,326 | $6.2M | 3/31/2026 |
| Amy Compton-Phillips | ▲ Buy | Grant | 5,569 | $400K | 3/31/2026 |
| James David Clark | ▲ Buy | Grant | 11,138 | $800K | 3/31/2026 |
| Heidi B. Capozzi | ▲ Buy | Grant | 10,025 | $720K | 3/31/2026 |
| John E. Gallina | ▲ Buy | Grant | 582 | $42K | 3/19/2026 |
| J. David Joyner | ▼ Sell | Tax Withholding | 1,944 | $155K | 2/28/2026 |
| Samrat S. Khichi | ▼ Sell | Tax Withholding | 7,886 | $628K | 2/28/2026 |
| Prem S. Shah | ▼ Sell | Tax Withholding | 247 | $20K | 1/1/2026 |
| James David Clark | ▼ Sell | Tax Withholding | 220 | $17K | 12/1/2025 |
| Tilak Mandadi | ▼ Sell | Tax Withholding | 6,575 | $528K | 11/30/2025 |
| Roger N. Farah | ▼ Sell | Tax Withholding | 9,748 | $783K | 11/30/2025 |
| Heidi B. Capozzi | ▼ Sell | Tax Withholding | 9,470 | $761K | 11/30/2025 |
| Douglas H. Shulman | ▲ Buy | Grant | 1,652 | $126K | 11/20/2025 |
| Guy P. Sansone | ▲ Buy | Grant | 1,652 | $126K | 11/20/2025 |
| Leslie Norwalk V | ▲ Buy | Grant | 1,652 | $126K | 11/20/2025 |
| J. Scott Kirby | ▲ Buy | Grant | 1,652 | $126K | 11/20/2025 |
| Finucane Anne A. | ▲ Buy | Grant | 591 | $45K | 11/20/2025 |
| C. David Brown II | ▲ Buy | Grant | 1,775 | $135K | 11/20/2025 |
| Jeffrey R. Balser | ▲ Buy | Grant | 1,775 | $135K | 11/20/2025 |
| Fernando Aguirre | ▲ Buy | Grant | 1,800 | $137K | 11/20/2025 |
| Prem S. Shah | ▼ Sell | Tax Withholding | 6,995 | $512K | 8/31/2025 |
| Tilak Mandadi | ▼ Sell | Tax Withholding | 12,834 | $939K | 8/31/2025 |
| Finucane Anne A. | ▼ Sell | Open Market | 7,500 | $533K | 8/20/2025 |
| Guy P. Sansone | ▲ Buy | Open Market | 1,570 | $100K | 6/5/2025 |
| Amy Compton-Phillips | ▲ Buy | Grant | 46,845 | $3.0M | 5/31/2025 |
| Brian Newman | ▲ Buy | Grant | 21,861 | $1.4M | 5/31/2025 |
| Amy Compton-Phillips | ▲ Buy | Grant | 6,246 | $400K | 5/31/2025 |
| J. Scott Kirby | ▲ Buy | Grant | 2,769 | $167K | 5/15/2025 |
| C. David Brown II | ▲ Buy | Grant | 2,232 | $135K | 5/15/2025 |
| Finucane Anne A. | ▲ Buy | Grant | 692 | $42K | 5/15/2025 |
| Fernando Aguirre | ▲ Buy | Grant | 2,263 | $137K | 5/15/2025 |
| Douglas H. Shulman | ▲ Buy | Grant | 2,077 | $126K | 5/15/2025 |
| Guy P. Sansone | ▲ Buy | Grant | 2,077 | $126K | 5/15/2025 |
| Leslie Norwalk V | ▲ Buy | Grant | 2,077 | $126K | 5/15/2025 |
| Michael F. Mahoney | ▲ Buy | Grant | 144 | $9K | 5/15/2025 |
| Jeffrey R. Balser | ▲ Buy | Grant | 2,232 | $135K | 5/15/2025 |
| Larry Robbins | ▼ Sell | Open Market | 150,000 | $10.0M | 5/6/2025 |
| Larry Robbins | ▼ Sell | Open Market | 1,226,933 | $82.7M | 5/5/2025 |
| Larry Robbins | ▼ Sell | Open Market | 96,999 | $6.6M | 5/5/2025 |
| Larry Robbins | ▼ Sell | Open Market | 222,556 | $15.2M | 5/2/2025 |
| Larry Robbins | ▼ Sell | Open Market | 373,776 | $26.0M | 5/2/2025 |
| Larry Robbins | ▼ Sell | Open Market | 1,679,736 | $113.2M | 5/2/2025 |
| J. David Joyner | ▼ Sell | Tax Withholding | 1,847 | $126K | 4/1/2025 |
| Prem S. Shah | ▼ Sell | Tax Withholding | 1,308 | $89K | 4/1/2025 |
| COWHEY THOMAS F. | ▼ Sell | Tax Withholding | 3,203 | $218K | 4/1/2025 |
| Heidi B. Capozzi | ▲ Buy | Grant | 11,768 | $800K | 4/1/2025 |
| Samrat S. Khichi | ▼ Sell | Tax Withholding | 1,548 | $105K | 4/1/2025 |
| James David Clark | ▲ Buy | Grant | 14,710 | $1000K | 4/1/2025 |
| Steven H. Nelson | ▲ Buy | Grant | 21,329 | $1.4M | 4/1/2025 |
| Tilak Mandadi | ▲ Buy | Grant | 20,594 | $1.4M | 4/1/2025 |
| Prem S. Shah | ▲ Buy | Grant | 26,478 | $1.8M | 4/1/2025 |
| Tilak Mandadi | ▼ Sell | Tax Withholding | 995 | $68K | 4/1/2025 |
| COWHEY THOMAS F. | ▲ Buy | Grant | 16,181 | $1.1M | 4/1/2025 |
| Samrat S. Khichi | ▲ Buy | Grant | 16,181 | $1.1M | 4/1/2025 |
| James David Clark | ▼ Sell | Tax Withholding | 2,266 | $154K | 4/1/2025 |
| Prem S. Shah | ▲ Buy | Option Exercise | 846 | $53K | 3/17/2025 |
| James David Clark | ▲ Buy | Option Exercise | 7,513 | $467K | 3/5/2025 |
| James David Clark | ▼ Sell | Open Market | 7,513 | $498K | 3/5/2025 |
| J. David Joyner | ▼ Sell | Tax Withholding | 1,944 | $128K | 2/28/2025 |
| Samrat S. Khichi | ▼ Sell | Tax Withholding | 5,604 | $368K | 2/28/2025 |
| COWHEY THOMAS F. | ▼ Sell | Tax Withholding | 5,318 | $349K | 2/28/2025 |
| Michael F. Mahoney | ▲ Buy | Open Market | 30,000 | $2.0M | 2/18/2025 |
| Steven H. Nelson | ▲ Buy | Open Market | 24 | $1K | 1/23/2025 |
| Finucane Anne A. | ▼ Sell | Gift | 2,665 | $152K | 12/5/2024 |
| Heidi B. Capozzi | ▲ Buy | Grant | 83,542 | $5.0M | 11/30/2024 |
| Tilak Mandadi | ▲ Buy | Grant | 50,125 | $3.0M | 11/30/2024 |
| James David Clark | ▼ Sell | Tax Withholding | 86 | $5K | 11/30/2024 |
| Roger N. Farah | ▲ Buy | Grant | 50,125 | $3.0M | 11/30/2024 |
| Leslie Norwalk V | ▲ Buy | Grant | 2,200 | $126K | 11/21/2024 |
| Fernando Aguirre | ▲ Buy | Grant | 2,364 | $135K | 11/21/2024 |
| Douglas H. Shulman | ▲ Buy | Grant | 2,200 | $126K | 11/21/2024 |
| Jeffrey R. Balser | ▲ Buy | Grant | 2,375 | $136K | 11/21/2024 |
| Guy P. Sansone | ▲ Buy | Grant | 2,200 | $126K | 11/21/2024 |
| MILLON JEAN PIERRE | ▲ Buy | Grant | 2,200 | $126K | 11/21/2024 |
| Michael F. Mahoney | ▲ Buy | Grant | 2,200 | $126K | 11/21/2024 |
| J. Scott Kirby | ▲ Buy | Grant | 2,933 | $167K | 11/21/2024 |
| DEPARLE NANCY ANN | ▲ Buy | Grant | 2,331 | $133K | 11/21/2024 |
| C. David Brown II | ▲ Buy | Grant | 2,331 | $133K | 11/21/2024 |
| Heidi B. Capozzi | ▲ Buy | Open Market | 35 | $2K | 10/23/2024 |
| Heidi B. Capozzi | ▲ Buy | Open Market | 10 | $622 | 10/2/2024 |
| Heidi B. Capozzi | ▲ Buy | Open Market | 35 | $2K | 9/9/2024 |
| Tilak Mandadi | ▼ Sell | Tax Withholding | 13,097 | $750K | 8/31/2024 |
| J. Scott Kirby | ▲ Buy | Grant | 2,912 | $167K | 5/16/2024 |
| Michael F. Mahoney | ▲ Buy | Grant | 2,184 | $126K | 5/16/2024 |
| MILLON JEAN PIERRE | ▲ Buy | Grant | 2,314 | $133K | 5/16/2024 |
| DEPARLE NANCY ANN | ▲ Buy | Grant | 2,314 | $133K | 5/16/2024 |
| C. David Brown II | ▲ Buy | Grant | 2,314 | $133K | 5/16/2024 |
| Jeffrey R. Balser | ▲ Buy | Grant | 2,184 | $126K | 5/16/2024 |
| Fernando Aguirre | ▲ Buy | Grant | 2,347 | $135K | 5/16/2024 |
| Edward J. Ludwig | ▲ Buy | Open Market | 1,000 | $54K | 5/2/2024 |
| Michael F. Mahoney | ▲ Buy | Open Market | 9,181 | $500K | 5/2/2024 |
| Prem S. Shah | ▼ Sell | Tax Withholding | 2,653 | $211K | 4/1/2024 |
| James David Clark | ▼ Sell | Tax Withholding | 1,112 | $88K | 4/1/2024 |
| Prem S. Shah | ▼ Sell | Tax Withholding | 5,239 | $417K | 4/1/2024 |
| James David Clark | ▼ Sell | Tax Withholding | 1,892 | $151K | 4/1/2024 |
| Prem S. Shah | ▲ Buy | Grant | 15,082 | $0 | 4/1/2024 |
| James David Clark | ▲ Buy | Grant | 10,683 | $850K | 4/1/2024 |
| Chaguturu Sreekanth K | ▼ Sell | Tax Withholding | 1,473 | $117K | 4/1/2024 |
| Chaguturu Sreekanth K | ▼ Sell | Tax Withholding | 825 | $66K | 4/1/2024 |
| Chaguturu Sreekanth K | ▲ Buy | Grant | 6,913 | $550K | 4/1/2024 |
| Havanec Laurie P. | ▼ Sell | Tax Withholding | 7,630 | $607K | 4/1/2024 |
| Havanec Laurie P. | ▲ Buy | Grant | 9,426 | $750K | 4/1/2024 |
| J. David Joyner | ▲ Buy | Grant | 28,280 | $0 | 4/1/2024 |
| Kane Brian A | ▲ Buy | Grant | 12,569 | $0 | 4/1/2024 |
| Samrat S. Khichi | ▲ Buy | Grant | 12,569 | $0 | 4/1/2024 |
| COWHEY THOMAS F. | ▼ Sell | Tax Withholding | 1,719 | $137K | 4/1/2024 |
| COWHEY THOMAS F. | ▲ Buy | Grant | 15,082 | $0 | 4/1/2024 |
| Tilak Mandadi | ▲ Buy | Grant | 16,339 | $0 | 4/1/2024 |
| Karen S. Lynch | ▲ Buy | Grant | 45,248 | $3.6M | 4/1/2024 |
| Karen S. Lynch | ▼ Sell | Tax Withholding | 61,953 | $4.9M | 4/1/2024 |
| J. David Joyner | ▼ Sell | Tax Withholding | 1,970 | $148K | 2/28/2024 |
| COWHEY THOMAS F. | ▼ Sell | Tax Withholding | 5,641 | $424K | 2/28/2024 |
| Samrat S. Khichi | ▼ Sell | Tax Withholding | 6,210 | $467K | 2/28/2024 |
| Prem S. Shah | ▼ Sell | Tax Withholding | 261 | $20K | 2/26/2024 |
| Chaguturu Sreekanth K | ▼ Sell | Tax Withholding | 355 | $27K | 2/26/2024 |
| Havanec Laurie P. | ▼ Sell | Tax Withholding | 6,698 | $512K | 2/26/2024 |
| Prem S. Shah | ▼ Sell | Open Market | 29,473 | $2.3M | 2/16/2024 |
| Chaguturu Sreekanth K | ▲ Buy | Grant | 1,926 | $0 | 2/12/2024 |
| Havanec Laurie P. | ▲ Buy | Grant | 16,817 | $0 | 2/12/2024 |
| James David Clark | ▲ Buy | Grant | 2,452 | $0 | 2/12/2024 |
| Prem S. Shah | ▲ Buy | Grant | 13,313 | $0 | 2/12/2024 |
| Karen S. Lynch | ▲ Buy | Grant | 136,640 | $0 | 2/12/2024 |
| James David Clark | ▼ Sell | Tax Withholding | 122 | $8K | 12/14/2023 |
| Finucane Anne A. | ▼ Sell | Gift | 3,450 | $256K | 12/7/2023 |
| COWHEY THOMAS F. | ▲ Buy | Grant | 7,358 | $500K | 11/30/2023 |
| Fernando Aguirre | ▲ Buy | Grant | 1,998 | $138K | 11/15/2023 |
| Finucane Anne A. | ▲ Buy | Grant | 1,925 | $133K | 11/15/2023 |
| DEPARLE NANCY ANN | ▲ Buy | Grant | 1,925 | $133K | 11/15/2023 |
| Jeffrey R. Balser | ▲ Buy | Grant | 1,817 | $126K | 11/15/2023 |
| MILLON JEAN PIERRE | ▲ Buy | Grant | 1,925 | $133K | 11/15/2023 |
| Michael F. Mahoney | ▲ Buy | Grant | 1,817 | $126K | 11/15/2023 |
| J. Scott Kirby | ▲ Buy | Grant | 2,422 | $167K | 11/15/2023 |
| Edward J. Ludwig | ▲ Buy | Open Market | 2,000 | $141K | 11/3/2023 |
| J. Scott Kirby | ▲ Buy | Grant | 299 | $21K | 10/2/2023 |
| Tilak Mandadi | ▼ Sell | Tax Withholding | 13,053 | $851K | 8/31/2023 |
| Prem S. Shah | ▼ Sell | Tax Withholding | 3,508 | $229K | 8/31/2023 |
| James David Clark | ▼ Sell | Open Market | 2,631 | $197K | 8/3/2023 |
| James David Clark | ▼ Sell | Open Market | 23,128 | $1.7M | 8/3/2023 |
| Fernando Aguirre | ▲ Buy | Grant | 1,329 | $92K | 5/18/2023 |
| DEPARLE NANCY ANN | ▲ Buy | Grant | 1,437 | $100K | 5/18/2023 |
| Finucane Anne A. | ▲ Buy | Grant | 1,437 | $100K | 5/18/2023 |
| MILLON JEAN PIERRE | ▲ Buy | Grant | 1,437 | $100K | 5/18/2023 |
| Jeffrey R. Balser | ▲ Buy | Grant | 1,329 | $92K | 5/18/2023 |
| Karen S. Lynch | ▲ Buy | Open Market | 14,000 | $977K | 5/3/2023 |
| James David Clark | ▲ Buy | Grant | 2,186 | $162K | 4/1/2023 |
| Chaguturu Sreekanth K | ▼ Sell | Tax Withholding | 1,854 | $138K | 4/1/2023 |
| Prem S. Shah | ▼ Sell | Tax Withholding | 3,221 | $239K | 4/1/2023 |
| Karen S. Lynch | ▼ Sell | Tax Withholding | 93,677 | $7.0M | 4/1/2023 |
| PELUSO MICHELLE A | ▼ Sell | Tax Withholding | 98,299 | $7.3M | 4/1/2023 |
| Finke Daniel P | ▼ Sell | Tax Withholding | 3,856 | $287K | 4/1/2023 |
| James David Clark | ▼ Sell | Tax Withholding | 1,471 | $109K | 4/1/2023 |
| Chaguturu Sreekanth K | ▼ Sell | Tax Withholding | 120 | $10K | 2/28/2023 |
| James David Clark | ▼ Sell | Tax Withholding | 179 | $15K | 2/28/2023 |
| Samrat S. Khichi | ▲ Buy | Grant | 47,881 | $4.0M | 2/28/2023 |
| J. David Joyner | ▲ Buy | Grant | 23,940 | $2.0M | 2/28/2023 |
| Prem S. Shah | ▼ Sell | Tax Withholding | 226 | $19K | 2/27/2023 |
| PELUSO MICHELLE A | ▼ Sell | Tax Withholding | 12,304 | $1.1M | 2/27/2023 |
| Havanec Laurie P. | ▼ Sell | Tax Withholding | 4,046 | $347K | 2/27/2023 |
| Chaguturu Sreekanth K | ▼ Sell | Tax Withholding | 318 | $27K | 2/27/2023 |
| Karen S. Lynch | ▲ Buy | Grant | 206,610 | $0 | 2/2/2023 |
| PELUSO MICHELLE A | ▲ Buy | Grant | 192,554 | $0 | 2/2/2023 |
| Moriarty Thomas M | ▼ Sell | Tax Withholding | 292,856 | $27.3M | 12/31/2022 |
| Moriarty Thomas M | ▼ Sell | Open Market | 36,490 | $3.6M | 12/15/2022 |
| Moriarty Thomas M | ▲ Buy | Option Exercise | 100,976 | $7.9M | 12/15/2022 |
| Moriarty Thomas M | ▼ Sell | Open Market | 100,976 | $9.9M | 12/15/2022 |
| Moriarty Thomas M | ▲ Buy | Option Exercise | 36,490 | $2.3M | 12/15/2022 |
| James David Clark | ▼ Sell | Tax Withholding | 153 | $16K | 12/1/2022 |
| Chaguturu Sreekanth K | ▼ Sell | Tax Withholding | 442 | $45K | 11/29/2022 |
| Finucane Anne A. | ▼ Sell | Gift | 800 | $78K | 11/18/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status
CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.